Effects of A3 adenosine receptor activation and gene knock-out in ischemic-reperfused mouse heart

被引:38
作者
Harrison, GJ
Cerniway, RJ
Peart, J
Berr, SS
Ashton, K
Regan, S
Matherne, GP
Headrick, JP
机构
[1] Griffith Univ, Heart Fdn Res Ctr, Southport, Qld, Australia
[2] Univ Virginia, Ctr Hlth Sci, Dept Pediat, Charlottesville, VA USA
[3] Univ Virginia, Ctr Hlth Sci, Cardiovasc Res Ctr, Charlottesville, VA USA
[4] Univ Virginia, Hlth Sci Ctr, Dept Radiol, Charlottesville, VA 22908 USA
关键词
adenosine; gene expression; ischemia; NMR; receptors; reperfusion; stunning;
D O I
10.1016/S0008-6363(01)00424-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To characterize effects of A, adenosine receptor (A(3)AR) activation and gene knock-out on responses to ischemia-reperfusion in mouse heart. Methods: Perfused hearts from wild-type and AA(3)R gene knock-out (A(3)AR KO) mice were subjected to 20 min ischemia and 30 min reperfusion. Functional responses were assessed and changes in energy metabolism and cytosolic pH monitored via P-31-NMR spectroscopy. Results: Selective A(3)AR agonism with 100 nM 2-chloro-N-6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide (chloro-IB-MECA) enhanced post-ischemic contractile recovery without altering contracture development in wild-type hearts, an effect unrelated to non-sciective activation of A, or A, adenosine receptors. Chloro-IB-MECA also improved recovery in hearts overexpressing A(3)ARs. Paradoxically, post-ischemic recovery was enhanced by A(3)AR KO. Developed pressure, +dP/dt, and -dP/dt all recovered to higher levels in A(3)AR KO (70-80% of pre-ischemia) vs. wild-type hearts (45-50% of pre-ischemia) (P<0.05). Enhanced recovery was unrelated to recoveries of ATP, phosphocreatine (PCr), inorganic phosphate (P-i), energy state ([ATP]/[ADP]. [P-i], DeltaG(ATP)) or cytosolic pH. Conclusions: Selective A(3)AR activation is cardioprotective in wild-type hearts and hearts overexpressing A(1)ARs, yet A3AR gene deletion generates an ischemia-tolerant phenotype without altering energy metabolism or pH. This may be due to to compensatory changes or undefined genotypic differences in A(3)AR KO vs. wild-type hearts. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:147 / 155
页数:9
相关论文
共 42 条
[11]   Alteration of glycogen and glucose metabolism in ischaemic and post-ischaemic working rat hearts by adenosine A1 receptor stimulation [J].
Fraser, H ;
Lopaschuk, GD ;
Clanachan, AS .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 (01) :197-205
[12]   Gene-targeting studies of mammalian behavior: Is it the mutation or the background genotype? [J].
Gerlai, R .
TRENDS IN NEUROSCIENCES, 1996, 19 (05) :177-181
[13]  
Grover GJ, 1996, CARDIOVASC RES, V31, P511
[14]   Targeted deletion of the A3 adenosine receptor confers resistance to myocardial ischemic injury and does not prevent early preconditioning [J].
Guo, Y ;
Bolli, R ;
Bao, W ;
Wu, WJ ;
Black, RG ;
Murphree, SS ;
Salvatore, CA ;
Jacobson, MA ;
Auchampach, JA .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (04) :825-830
[15]   Functional and metabolic effects of extracellular magnesium in normoxic and ischemic myocardium [J].
Headrick, JP ;
McKirdy, JC ;
Willis, RJ .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 275 (03) :H917-H929
[16]   Transgenic A1 adenosine receptor overexpression markedly improves myocardial energy state during ischemia-reperfusion [J].
Headrick, JP ;
Gauthier, NS ;
Berr, SS ;
Morrison, RR ;
Matherne, GP .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1998, 30 (05) :1059-1064
[17]   Relative importance of adenosine A1 and A3 receptors in mediating physiological or pharmacological protection from ischemic myocardial injury in the rabbit heart [J].
Hill, RJ ;
Oleynek, JJ ;
Magee, W ;
Knight, DR ;
Tracey, WR .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1998, 30 (03) :579-585
[18]   Adenosine A3 receptors:: novel ligands and paradoxical effects [J].
Jacobson, KA .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (05) :184-191
[19]  
Jones R, 1999, CIRCULATION, V100, P715
[20]  
Jordan JE, 1997, J PHARMACOL EXP THER, V280, P301